Suchergebnisse - "Cariou, Bertrand"

PubPharm (5)

1

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

enthalten in: BMC cardiovascular disorders | 2019

von Schmidt, A. | Holmes, M. | Preiss, D. | +162

2

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

enthalten in: BMC cardiovascular disorders | 2019

von Schmidt, A. | Holmes, M. | Preiss, D. | +162

3

Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins : rationale and design of the ODYSSEY COMBO I and II trials

enthalten in: BMC cardiovascular disorders | 2014

von Colhoun, H. | Robinson, J. | Farnier, M. | +6

4

Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials

enthalten in: BMC cardiovascular disorders | 2014

von Colhoun, H. | Robinson, J. | Farnier, M. | +6

5

Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials

enthalten in: BMC cardiovascular disorders | 2014

von Colhoun, H. | Robinson, J. | Farnier, M. | +6

1
[1]